| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Revenue | $22.2M | +4.2% |
| Cost of Revenue | $7.0M | +7.2% |
| Gross Profit | $15.2M | +2.9% |
| R&D Expense | $2.2M | -25.0% |
| SG&A Expense | $7.9M | +0.4% |
| Operating Income | $5.0M | +29.3% |
| Pre-tax Income | $5.1M | -2.3% |
| Income Tax | $831K | +172.1% |
| Net Income | $4.3M |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.9M | +29.2% |
| Accounts Receivable | $2.9M | -31.8% |
| Inventory | $10.0M | -6.2% |
| Current Assets | $37.0M | +4.1% |
| Total Assets | $46.9M | +3.2% |
| Current Liabilities | $3.5M | -18.5% |
| Total Liabilities | $3.5M | -19.7% |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.7M | +105.7% |
| Capital Expenditures | $466K | -45.2% |
| Investing Cash Flow | -$557K | +42.3% |
| Financing Cash Flow | -$92K | -166.0% |
| Free Cash Flow | $6.3M | +158.8% |
| -13.1% |
| EPS (Basic) | $0.40 | -13.0% |
| EPS (Diluted) | $0.38 | -13.6% |
| Stockholders' Equity |
| $43.4M |
| +5.7% |